Lupin and Boehringer Ingelheim partner to develop and commercialise novel oncology drug to treat…
The partnership aims to develop Lupin’s lead MEK inhibitor compound in combination with one of Boehringer Ingelheim’s innovative…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin’s South African arm Pharma Dynamics signs commercial agreement with Creso Pharma
The agreement gives Pharma Dynamics distribution rights hemp oil-based cannaQIX products across South Africa, Namibia, Botswana,…
Lupin to sell Japanese Injectables business to Neopharma Group
The transaction is subject to customary closing conditions, has been approved by BoD of Lupin
Lupin Q1 net profit up 49 pc to Rs 303.05
The company had posted a net profit of Rs 202.76 crore in the year-ago period
Lupin’s Mandideep facility inspection completed by ANSM
The inspection closed with no critical or major observations
Lupin gets EIR from USFDA for Aurangabad facility
The facility was inspected by the US Food and Drug Administration (US FDA) between May 6-15, 2019, Lupin said in a BSE filing
OPPI organises conference on future of supply chain management in Mumbai
Key stakeholders of the pharma industry congregated at the event to confer and converse on the blueprint to build an effective and…
Notices issued to companies for introducing drugs without prior nod from NPPA: Government
The drugs include those used for treating conditions like diabetes, inflammation and chronic hepatitis C, among others
Lupin’s Nagpur facility won ENR Global Best Project Award
The award was given to Lupin’s Oral Solid Dosage (OSD) and Injectable Pharmaceutical Manufacturing Facility at Nagpur
Lupin aims to launch new products across geographies this fiscal
"Looking ahead, FY2020 is an exciting year for Lupin as we plan to bring our first biosimilar to market and commercialise our…